Quinenco (QUINENCO)
Santiago Stock Exchange · Chile · prices in CLP · close of 27 Oct 2026
Key indicators
| Last close | CLP 4,450.00 |
|---|---|
| 52-week range | 3,501.00 – 4,920.00 |
| Return, 1 month / 3 months | −7.4% / +3.7% |
| Return, 1 year / 3 years | +14.8% / +157.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 22.2% |
| Worst drawdown (1 year) | -13.9% |
| Average daily value traded | 1,462.63M CLP |
| Dividend yield | 9.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Quinenco is a Chilean holding company based in Santiago that owns stakes in businesses across several industries. Through its investments it is involved in banking, beverages and food production, electrical cables and telecommunications, energy, and port operations. Its holdings serve consumers and industrial customers in Chile and other Latin American markets, and the company operates as an investment vehicle that manages these participations rather than making a single product of its own.
The shares are listed on the Santiago Stock Exchange in Chile under the code QUINENCO, and the price on this page is in Chilean pesos (CLP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Quinenco (QUINENCO) trades on the Santiago Stock Exchange in Chile. It last closed at CLP 4,450.00 on 27 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 20 of 112 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.8% and over the last three months it rose 3.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Santiago Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.6% | ||
| From 52-week high | -9.6% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.7% | ||
| 6-month return | 9.5% | ||
| 12-month return, skipping the last month | 24.0% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 22.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.9% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 1,462.63M CLP | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 9.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.9% |
|---|---|
| 1 month | −7.4% |
| 3 months | +3.7% |
| 6 months | +9.5% |
| 1 year | +14.8% |
| 3 years | +157.6% |
| 5 years | +504.6% |
Signals
| 50-day / 200-day average | 4,660.35 / 4,213.91 |
|---|---|
| Golden / death cross (60 days) | Golden, 59 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 131.52 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2026 | CLP 349.0389 |
| 15 Dec 2025 | CLP 60.1410 |
| 16 Dec 2024 | CLP 120.2820 |
| 17 May 2024 | CLP 450.0000 |
| 6 May 2024 | CLP 151.9102 |
| 22 May 2023 | CLP 637.8532 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Santiago Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.